Science 37 Holdings, Inc.

Science 37 Holdings, Inc. (Nasdaq: SNCE) is a decentralized clinical trial technology company that became publicly traded in October 2021 following its business combination with LifeSci Acquisition 2 Corp., a blank-check vehicle sponsored by LifeSci Capital. The company filed a Form 10-K/A — an amended annual report — with the SEC on December 20, 2021, representing one of its earliest annual disclosures as a newly public entity. Science 37 operates in the healthcare technology and clinical research services sector, providing a platform that enables remote and patient-centric trial operations for biopharma sponsors. Sign up at SpacDesk for full filing history, sponsor profiles, and deal analytics on SNCE.